Fingolimod Capsules 0.5 mg

Fingolimod Capsules 0.5 mg
Product Description

Fingolimod, a sphingosine-1-phosphate (S1P) receptor modulator, is an effective therapy for Relapsing-Remitting Multiple Sclerosis (RRMS) that reduces relapses, slows disability progression, and enhances patient quality of life.

 Mechanism of Action (MOA): Modulates S1P receptors, which regulate immune cell migration. Retains lymphocytes in lymph nodes, preventing their entry into the central nervous system (CNS), thereby reducing inflammation and damage in Multiple Sclerosis (MS).

Therapeutic Uses:

Treats RRMS.
Enhances overall well-being in MS patients.

Read more Show less

Swasthya Healthcare Private Limited

  • IN
  • 2022
    On CPHI since
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less

Swasthya Healthcare Private Limited

  • IN
  • 2022
    On CPHI since
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
View company profile

More Products from Swasthya Healthcare Private Limited (2)

  • Iohexol Injection USP 300mg-50ml

    Product Iohexol Injection USP 300mg-50ml

     Product Overview: Iohexol is widely used in computed tomography (CT) scans, angiography, and urography to improve image clarity, enabling precise diagnosis and treatment planning.

     Key Features:

    High-contrast enhancement for detailed imaging Excellent safety profile with l...
  • Leuprolide Depot Injection 22.5 mg

    Product Leuprolide Depot Injection 22.5 mg

    Mechanism of Action (MOA): Leuprolide acts as a GnRH agonist, initially stimulating but eventually suppressing LH & FSH secretion, leading to decreased testosterone in men and estrogen in women.
    Therapeutic UsProstate Cancer – Advanced and hormone-dependent cases
     Endometriosis – Sympto...

Recently Visited